952 related articles for article (PubMed ID: 10919738)
1. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
[TBL] [Abstract][Full Text] [Related]
2. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
3. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
Bardia A; Hartmann LC; Vachon CM; Vierkant RA; Wang AH; Olson JE; Sellers TA; Cerhan JR
Arch Intern Med; 2006 Dec 11-25; 166(22):2478-83. PubMed ID: 17159013
[TBL] [Abstract][Full Text] [Related]
4. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.
Vrieling A; Buck K; Kaaks R; Chang-Claude J
Breast Cancer Res Treat; 2010 Oct; 123(3):641-9. PubMed ID: 20711809
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
7. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
[TBL] [Abstract][Full Text] [Related]
8. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
9. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
10. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
Nichols HB; Trentham-Dietz A; Love RR; Hampton JM; Hoang Anh PT; Allred DC; Mohsin SK; Newcomb PA
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):41-7. PubMed ID: 15668474
[TBL] [Abstract][Full Text] [Related]
11. Energy balance and breast cancer risk: a prospective cohort study.
Silvera SA; Jain M; Howe GR; Miller AB; Rohan TE
Breast Cancer Res Treat; 2006 May; 97(1):97-106. PubMed ID: 16319973
[TBL] [Abstract][Full Text] [Related]
12. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States).
Li CI; Malone KE; Daling JR
Cancer Causes Control; 2006 Jun; 17(5):695-703. PubMed ID: 16633917
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
[TBL] [Abstract][Full Text] [Related]
14. Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status.
Zhang M; Yang H; Holman CD
Breast Cancer Res Treat; 2009 Dec; 118(3):553-63. PubMed ID: 19252980
[TBL] [Abstract][Full Text] [Related]
15. Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors.
Barnes BB; Steindorf K; Hein R; Flesch-Janys D; Chang-Claude J
Cancer Epidemiol; 2011 Aug; 35(4):345-52. PubMed ID: 21159569
[TBL] [Abstract][Full Text] [Related]
16. Early-life physical activity and postmenopausal breast cancer: effect of body size and weight change.
Shoff SM; Newcomb PA; Trentham-Dietz A; Remington PL; Mittendorf R; Greenberg ER; Willett WC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):591-5. PubMed ID: 10868694
[TBL] [Abstract][Full Text] [Related]
17. Survival of women with node negative breast cancer in the Auckland region.
Lethaby AE; Mason BH; Harvey VJ; Holdaway IM
N Z Med J; 1996 Sep; 109(1029):330-3. PubMed ID: 8862351
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status.
Rusiecki JA; Holford TR; Zahm SH; Zheng T
Cancer Detect Prev; 2005; 29(5):419-26. PubMed ID: 16185815
[TBL] [Abstract][Full Text] [Related]
19. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers associated with breast cancer are associated with obesity.
Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
